Patients News | pharmaphorum

News

Vydura is NHS’ first oral CGRP for migraine prevention

Pfizer’s Vydura has become the first oral CGRP antagonist recommended for routine use by the NHS to prevent episodic migraine attacks, after being rejected earlier this ye

News

Parkinson’s wearable matches experts in clinical trial

A new clinical study has found that a wearable device developed by PD Neurotechnology was 95% accurate in detecting and assessing motor symptoms of Parkinson’s disease, wh

News

UK funds extended reality projects for mental health

Innovate UK has funded three projects in its Mindset programme, which aims to support the development of extended and

News

Primary care a weak link in trials, says O’Shaughnessy

Primary care doctors in the UK are a “negligible” provider of commercial clinical trial activity and should be incentivised to give experimental therapies to patients.

News

Virtual ward firm Doccla starts atrial fibrillation project

A new partnership between virtual ward start-up Doccla, wearable tech company AliveCor, and a UK healthcare trust will examine the care of patients with

News

AI-based infectious disease detector gets UK funding

The UK government has agreed to support the development of a rapid diagnostic from Oxford medtech firm Pictura Bio that could help manage infectious diseases amongst milit

Vydura is NHS’ first oral CGRP for migraine prevention

Parkinson’s wearable matches experts in clinical trial

UK funds extended reality projects for mental health

Primary care a weak link in trials, says O’Shaughnessy

Virtual ward firm Doccla starts atrial fibrillation project

AI-based infectious disease detector gets UK funding

Senju launches first-in-class dry eye disease drug in Japan

Using AI-driven synthetic personas to take your insights fur...

News

Editor's Picks